Show simple item record

dc.contributor.authorHacisalihoglu, U. P.
dc.contributor.authorDogan, M. A.
dc.date.accessioned2021-12-21T08:45:59Z
dc.date.available2021-12-21T08:45:59Z
dc.identifier.issn1052-0295
dc.identifier.issn1473-7760
dc.identifier.urihttps://doi.org/10.1080/10520295.2021.1973102
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1855
dc.description.abstractBreast cancer treatment is tailored to molecular subtypes, which are classified by cell type and by presence of estrogen and progesterone receptors, HER2 overexpression and Ki-67 proliferation index. In routine pathological practice, these markers are det
dc.language.isoEnglish
dc.publisherTaylor & Francıs Ltd
dc.titleExpression of estrogen and progesterone receptors, HER2 protein and Ki-67 proliferation index in breast carcinoma in both tumor tissue and tissue microarray
dc.typeArticle; Early Access
dc.relation.journalBıotechnıc & Hıstochemıstry
dc.identifier.doi10.1080/10520295.2021.1973102


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record